Is FTRE or GENB more undervalued in 2026?

CirclFi compares Fortrea Holdings Inc. (FTRE) and Generate Biomedicines, Inc. (GENB) using 13 institutional-grade valuation models. FTRE has a Quality of Company score of 5.3/10 while GENB scores 1.8/10.

Which is a better buy — FTRE or GENB?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do FTRE and GENB valuations compare?

FTRE at $15.00 and GENB at $13.09 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

FTRE vs GENB Valuation Comparison 2026 — Intrinsic Value Analysis

FTRE

Biotechnology

Fortrea Holdings Inc.

Quality

5.3

out of 10

Value Trap

LOW

Price

$15.00

Last close

Models

9/13

Active

GENB

Biotechnology

Generate Biomedicines, Inc.

Quality

1.8

out of 10

Value Trap

—

Price

$13.09

Last close

Models

8/13

Active

Model-by-Model Comparison

Model	Type	FTRE Fair Value	FTRE Upside	GENB Fair Value	GENB Upside
Bayesian DCF	Intrinsic	$0.17	-98.8%	$3.47	-73.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$12.15	-19.0%	$0.66	-95.9%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$27.66	+84.4%	$8.93	-31.7%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for FTRE vs GENB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

FTRE vs GENB — Which Stock Is More Undervalued?

FTRE scores higher with a 5.3/10 quality rating vs GENB's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Fortrea Holdings Inc. (FTRE) and Generate Biomedicines, Inc. (GENB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

FTRE currently trades at $15.00 with a QOC of 5.3/10, while GENB trades at $13.09 with a QOC of 1.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).